Flavonoid glycosides inhibit oral cancer cell proliferation - Role of cellular uptake and hydrolysis to the aglycones

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 8, 2005, Pages 1037-1041

  Browning, Alyson M ^a   Walle, U Kristina ^a   Walle, Thomas ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE DERIVATIVE; DIOSMETIN; DIOSMIN; FLAVONOID GLYCOSIDE; GENISTEIN; GENISTIN; GLYCOSIDE; QUERCETIN; QUERCITRIN; SPIRAEOSIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; EPIDEMIOLOGICAL DATA; HUMAN; HUMAN CELL; HYDROLYSIS; MOUTH CANCER; SALIVA ANALYSIS; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DIET; DIOSMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GLYCOSIDES; HUMANS; HYDROLYSIS; ISOFLAVONES; MOUTH NEOPLASMS; QUERCETIN;

EID: 22844440224     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357056514     Document Type: Article

References (23)

1. Arts, I. C., Sesink, A. L., Faassen-Peters, M., Hollman, P. C. (2004) The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides. Br. J. Nutr. 91: 841-847
2. Barnes, S., Kirk, M., Coward, L. (1994) Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J. Agric. Food Chem. 42: 2466-2474
3. Block, G., Patterson, B., Subar, A. (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 18: 1-29
4. Ciolino, H. P., Wang, T. T. Y., Yeh, G. C. (1998) Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res. 58: 2754-2760
5. Day, A. J., DuPont, M. S., Ridley, S., Rhodes, M., Rhodes, M. J. C., Morgan, M. R. A., Williamson, G. (1998) Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett. 436: 71-75
6. 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. J. Pharm. Sci. 91: 32-40
7. Havsteen, B. H. (2002) The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96: 67-202
8. Kiviranta, J., Huovinen, K., Hiltunen, R. (1988) Variation of phenolic substances in onion. Acta Pharm. Fenn. 97: 67-72
9. Levi, F., Pasche, C., La Vecchia, C., Lucchini, F., Franceschi, S., Monnier, P. (1998) Food groups and risk of oral and pharyngeal cancer. Int. J. Cancer 77: 705-709
10. Middleton, E. J., Kandaswami, C., Theoharides, T. C. (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52: 673-751
11. Morrow, D., Qin, C., Smith, R. I., Safe, S. (2004) Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation. J. Steroid Biochem. Mol. Biol. 88: 27-36
12. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63
13. Oyama, Y., Yamano, H., Ohkuma, A., Ogawara, K.-I., Higaki, K., Kimura, T. (1999) Carrier-mediated transport systems for glucose in mucosal cells of the human oral cavity. J. Pharm. Sci. 88: 830-834
14. Rice-Evans, C. (2001) Flavonoid antioxidants. Curr. Med. Chem. 8: 797-807
15. Sakagami, H., Oi, T., Satoh, K. (1999) Prevention of oral diseases by polyphenols (review). In Vivo 13: 155-172
16. Vita, J. A. (2005) Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am. J. Clin. Nutr. 81 (Suppl.): 292S-297S
17. Walgren, R. A., Walle, U. K., Walle, T. (1998) Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 55: 1721-1727
18. Walgren, R. A., Karnaky, K. J., Lindenmayer, G. E., Walle, T. (2000a) Efflux of dietary flavonoid quercetin 4′-β-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J. Pharmacol. Exp. Ther. 294: 830-836
19. Walgren, R. A., Lin, J.-T., Kinne, R. K.-H., Walle, T. (2000b) Cellular uptake of dietary flavonoid quercetin 4′-β-glucoside by sodium-dependent glucose transporter SGLT1. J. Pharmacol. Exp. Ther. 294: 837-843
20. Walle, T. (2004) Absorption and metabolism of flavonoids. Free Radic. Biol. Med. 36: 829-837
21. Walle, T., Walle, U. K. (2003) The β-D-glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2. Drug Metab. Dispos. 31: 1288-1291
22. Walle, T., Browning, A. M., Steed, L. S., Reed, S. G., Walle, U. K. (2005) Flavonoid glucoside are hydrolyzed and thus activated in the oral cavity in humans. J. Nutr. 135: 48-52
23. Walle, U. K., French, K. L., Walgren, R. A., Walle, T. (1999) Transport of genistein-7-glucoside by human intestinal Caco-2 cells: potential role for MRP2. Res. Commun. Mol. Pathol. Pharmacol. 103: 45-56